Drug Design Reviews - Online

The Central Sympathetic Nervous System: A New Target for Cardioprotective Drugs
pp. 259-266(8)
Authors: Tibirica, E.; Lessa, M. A.

Role of Secondary Alcohol Metabolites in Anthracycline Cardiotoxicity: from Hypotheses to New Drugs
pp. 267-276(10)
Authors: Salvatorelli, Emanuela; Minotti, Giorgio; Menna, Pierantonio

Computer-Aided Drug Design: Structure-Activity Relationships of Delta Opioid Ligands
pp. 277-291(15)
Authors: Bernard, Denzil; Coop, Andrew; MacKerell Jr., Alexander D.

Compounds that Combine Aldose Reductase Inhibitory Activity and Ability to Prevent the Glycation (Glucation and/or Fructation) of Proteins as Putative Pharmacotherapeutic Agents
pp. 293-304(12)
Authors: Demopoulos, Vassilis J.; Zaher, Nazlaa; Zika, Chariklia; Anagnostou, Costas; Mamadou, Edouard; Alexiou, Polyxeni; Nicolaou, Ioannis

Leucine-Rich Repeats (LRRs): Structure, Function, Evolution and Interaction with Ligands
pp. 305-322(18)
Authors: Matsushima, Norio; Enkhbayar, Purevjav; Kamiya, Masakatsu; Osaki, Mitsuru; Kretsinger, Robert H.

Nucleic Acid-Based Gene-Silencing Molecules as Potential Antiviral Therapeutics
pp. 323-333(11)
Authors: Yuan, Ji; Chen, Zhongbin; Cheung, Paul; Chau, David; Yang, Decheng

The Chronic Painful Tendon-Vasculo/Neural Ingrowth the Target for Therapy
pp. 335-339(5)
Author: Alfredson, Hakan